Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS

Life Sciences Researchimb.savba.sk

The Institute of Molecular Biology SAS (IMB SAS) is a Slovak Academy of Sciences public research institute in Bratislava, Slovakia, conducting basic and applied research in microbial genetics, microbial ecology, genomics and biotechnology, and protein biochemistry, and maintaining open-access bioinformatics databases for the global scientific community.

Company typePrivate
Founded-
Headquarters—
Headcount1–10
GTM typeB2B
OfferingServices

What Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS does

Ústav molekulárnej biológie SAV, v. v. i. (Institute of Molecular Biology SAS, IMB SAS) is a public research institution (verejná výskumná inštitúcia) headquartered in Bratislava, Slovakia, operating under the Slovak Academy of Sciences (Slovenská akadémia vied, SAV). The institute is organized into four scientific departments: Microbial Genetics (led by RNDr. Imrich Barák, DrSc.), Microbial Ecology (led by Dr. Domenico Pangallo, DrSc.), Genomics and Biotechnology (led by RNDr. Ján Kormanec, DrSc.), and Biochemistry and Protein Structure (led by prof. Ing. Štefan Janeček, DrSc.). Research spans cell division, sporulation, and programmed cell death in Bacillus subtilis; environmental and food microbiology including microbial communities affecting cultural heritage and traditional Slovak foods; bacteriophage biology, sigma factors, streptomycete differentiation, and secondary metabolites; and mitochondrial proteostasis, protein evolution, and amylase enzyme families. The institute additionally houses laboratories in Apidology and Apitherapy (bee-product therapies for chronic wound healing) and Synthetic Microbiology (G-quadruplex DNA as genetic regulators).

IMB SAS develops and maintains a suite of proprietary bioinformatics resources for the global scientific community: the phiSITE database (gene regulation and phage genomics, with the phiGENOME visualization tool), the phiBIOTICS database (enzybiotics and phage therapy), the phiBiScan predictive tool (enzybiotic prediction from primary protein structure), and the viruSITE database (viral genomics). The institute operates EMBnet's national node and supports the Biologia journal (impact factor 1.500). It collaborates internationally with institutions including EPFL, Royal Holloway University of London, University of York, European XFEL, Changchun Institute of Applied Chemistry (CAS), National Cheng Kung University (Taiwan), and multiple German, Italian, Polish, and Czech partners.

IMB SAS is a non-commercial public entity with no pricing model; it is funded by the Slovak government through the Slovak Academy of Sciences and competitive research grants. Its "customers" in the broadest sense are the global academic and biomedical research community that consumes its open-access databases, scientific publications, and collaborative research outputs. Outreach extends to the Slovak general public through science festivals, school programs, and media appearances.

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS firmographics

Firmographics

Name: Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS
Legal name: Ústav molekulárnej biológie SAV, v. v. i.
Website: https://imb.savba.sk
Company type: Private
Operating status: Operating
Headcount range: 1–10 employees
Short description: The Institute of Molecular Biology SAS (IMB SAS) is a Slovak Academy of Sciences public research institute in Bratislava, Slovakia, conducting basic and applied research in microbial genetics, microbial ecology, genomics and biotechnology, and protein biochemistry, and maintaining open-access bioinformatics databases for the global scientific community.
Ownership category
akta.pro rank

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS industry classification

Industry

Product category: Life Sciences Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC: Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
akta.pro secondary industry: Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

Molecular biology research
Bioinformatics databases
Phage genomics
Microbial genetics
Protein biochemistry

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS product offering

Product offering

Core offering

The Institute of Molecular Biology SAS is a public research institution that conducts fundamental and applied research in microbial genetics, microbial ecology, genomics and biotechnology, and biochemistry and protein structure. It develops and maintains open-access bioinformatics databases and tools (phiSITE, phiBIOTICS, phiBiScan, viruSITE, phiGENOME) for the global scientific community and produces peer-reviewed publications and international collaborative research outputs.

Product overview

IMB SAS is a molecular biology research institute (part of the Slovak Academy of Sciences) that maintains several bioinformatics databases and tools for phage research, gene regulation analysis, and viral genomics. The primary offerings are phiSITE (gene regulation and phage genomics database), phiBIOTICS (enzybiotic database), phiBiScan (enzybiotic prediction tool), and viruSITE (viral database), with phiGENOME as an integrated visualization component within phiSITE. These are research databases and tools developed by the institute's Bioinformatics group for the scientific community.

Differentiator

Problem solved

Functional benefit

Products and services

phiSITE Database

Companies that use Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS

Customer profile

Segments2 records

Ideal customer profiles2 records

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core and major.

Biological Physical Sciences Institute, University of YorkcoreStrategic or Co-development PartnerInternational scientific collaboration in molecular biology research, part of ongoing research projects and joint publications.
Changchun Institute of Applied Chemistry, Chinese Academy of SciencescoreStrategic or Co-development PartnerCollaborative research partnership in applied chemistry and biotechnology applications.
Department of Biochemistry & Biotechnology, University of ThessalycoreStrategic or Co-development PartnerCollaboration in biochemistry and biotechnology research with Greek research institutions.
Department of Chemistry, University of YorkcoreStrategic or Co-development PartnerJoint research in chemistry-related molecular biology applications.
Faculty of Chemistry, Gdansk University of TechnologycoreStrategic or Co-development PartnerCollaboration in pharmaceutical technology and biochemistry with Polish partners.
University of Piemonte Orientale (DISIT)coreStrategic or Co-development PartnerScientific collaboration in innovative technologies with Italian university partners.
EPFL (École Polytechnique Fédérale de Lausanne)coreStrategic or Co-development PartnerCollaboration with Swiss Federal Institute of Technology in Lausanne for advanced research projects.
Royal Holloway, University of LondoncoreStrategic or Co-development PartnerPartnership with UK university for molecular biology research collaboration.
European XFEL (XFEL)coreStrategic or Co-development PartnerCollaboration on X-ray free electron laser experiments for life science research at European XFEL facility in Hamburg.
Istituto Centrale per il Restauro e la Conservazione del Patrimonio Archivistico e Librario (Rome)majorStrategic or Co-development PartnerCollaboration on cultural heritage preservation and microbial analysis of archival materials with Italian institution.
Institute of Fermentation Technology and Microbiology, Lodz University of TechnologycoreStrategic or Co-development PartnerPartnership in fermentation technology and microbiology research with Polish institution.
Department of Chemical Technology of Monument Conservation, University of Chemistry and Technology PraguecoreStrategic or Co-development PartnerCollaboration on chemical technologies for monument conservation with Czech partners.
National Cheng Kung University, TaiwancoreStrategic or Co-development PartnerInternational collaboration with Taiwanese university in environmental engineering and biotechnology.
CNR - Institute for Biomedical Technologies, Bari, ItalycoreStrategic or Co-development PartnerBiomedical technologies collaboration with Italian National Research Council.
Institut fuer Genomforschung und Systembiologie, CeBiTec, University of BielefeldcoreStrategic or Co-development PartnerCollaboration on genome research and systems biology with leading German bioinformatics center.
Department of Veterinary Pathology, Glasgow University Veterinary SchoolcoreStrategic or Co-development PartnerPartnership with UK veterinary school for pathology and molecular research.
Institute of Medical Microbiology and Hygiene, University of Saarland HospitalcoreStrategic or Co-development PartnerCollaboration with German university hospital on medical microbiology research.
Institute of Life Science, School of Medicine, Swansea UniversitycoreStrategic or Co-development PartnerPartnership with Welsh university medical school for life science research.
Sweden Biomedical Centre (Sweden)coreStrategic or Co-development PartnerCollaboration with Swedish biomedical research center; EMBnet national node management.

Recent moves6 records

Expansion highlights4 records

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS competitors and assessment

Company assessment

Broad incumbents

European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with sites across Europe. Comparable as a peer because EMBL operates extensive bioinformatics and genomics infrastructure (e.g., EBI databases), which closely parallels the phiSITE, phiBIOTICS, and viruSITE database ecosystem maintained by IMB SAS for the global scientific community.
John Innes Centre: UK-based independent research institute focused on microbial biology, plant science, and bioinformatics with extensive Bacillus subtilis research programs. Directly comparable as a peer because of overlapping microbiology and bacterial genetics research domains, particularly relevant given IMB SAS's focus on Bacillus subtilis sporulation and cell division in the Microbial Genetics department.
Wellcome Sanger Institute: UK-based genomic research institute conducting large-scale genomic and bioinformatics research with extensive database outputs. Comparable because of overlapping focus on genomics infrastructure and databases, paralleling IMB SAS's viruSITE and phiSITE database efforts — though at materially greater scale.
Pasteur Institute: Prestigious French non-profit research institute specializing in microbiology, virology, and immunology with global bioinformatics resources. Highly comparable as a peer because of significant overlap with IMB SAS's work on phage biology, virology research (viruSITE), and bacterial genetics, while also representing a much larger established authority in the same fundamental research domains.
VTT Technical Research Centre of Finland (Biotechnology): Finnish public research institute with industrial biotechnology research programs including microbial biotechnology, synthetic biology, and protein engineering. Comparable as a peer because it shares a publicly funded applied biotechnology research structure with industrial translation pathways — adjacent to IMB SAS's synthetic microbiology and protein structure research directions.
Max Planck Institute for Molecular Genetics: Large-scale molecular biology research institute in Berlin conducting research in genome regulation, developmental genetics, and computational biology. Highly comparable as a peer because it operates as a publicly funded research institute producing molecular biology knowledge and tools, with structural parallels to IMB SAS's departmental research model in microbial genetics and genomics.

Regional players

Institute of Molecular Biosciences, University of Graz: Austrian university-affiliated molecular biosciences research institute studying biochemistry, molecular biology, and microbiology. Comparable as a regional peer because it operates in Central Europe with overlapping molecular biology and protein biochemistry research, similar in scale and academic orientation to IMB SAS.

Direct peers

Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI): German research institute studying natural product discovery and infection biology, including actinomycete secondary metabolites and antimicrobial compounds. Comparable as a peer due to direct overlap with IMB SAS's Genomics and Biotechnology department work on streptomycete differentiation, auricin antibiotics, and antimicrobial discovery.
Institute of Molecular Biology (IMB), Mainz: Germany-based molecular life sciences research institute covering epigenetics, DNA repair, quantitative and computational biology. Directly comparable because it operates at a similar scale as a dedicated molecular biology research center, maintaining its own faculty-led research groups and serving as a Europe-wide node in molecular biology — matching IMB SAS's focus on mechanistic studies of fundamental cellular processes.
Institute of Molecular Biology and Biotechnology (IMBB), FORTH: Greek Foundation for Research and Technology research institute covering molecular biology, biotechnology, and bioinformatics. Directly comparable as a peer because it shares academic-public funding structure, conducts molecular biology research with bioinformatics components, and operates at a similar scale to IMB SAS in a comparable European academic ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights7 records

Customer concentration

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS leadership team

Management profile

Number of profiles

Profiles4 records

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS

What does Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS do?

Is Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS a public or private company?

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS is a private company. It is classified as state government owned and is currently operating.

When was Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS founded?

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS was founded in -1. It employs 1 to 10 people.

Who are Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS's main competitors?

Broad incumbents on record are European Molecular Biology Laboratory (EMBL), John Innes Centre, Wellcome Sanger Institute, Pasteur Institute, VTT Technical Research Centre of Finland (Biotechnology) and Max Planck Institute for Molecular Genetics. Institute of Molecular Biosciences, University of Graz is listed as a regional player. Direct peers are Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), Institute of Molecular Biology (IMB), Mainz and Institute of Molecular Biology and Biotechnology (IMBB), FORTH.

Does Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS have an API?

No public API is recorded for Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS.

What industry is Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS in?

Ústav molekulárnej biológie SAV, v. v. i. / Institute of Molecular Biology SAS's product category is Life Sciences Research. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels). Its NAICS code is 541714 and its SIC code is 8731.